Financial institutions raise Doximity price targets to $32-35 per share after Q3 EPS beat.
Financial institutions including Bank of America, Morgan Stanley and Barclays have raised their price targets for healthcare tech company Doximity, with some targeting $32-35 per share. Doximity shares, trading under NASDAQ ticker DOCS, have gained $9.94 during mid-day trading, reaching $35.60 after the company reported $0.22 EPS for its last quarter, exceeding the consensus estimate of $0.16.
August 11, 2024
4 Articles